Holding(s) in Company

RNS Number : 5624C
Deltex Medical Group PLC
16 November 2009
 




TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

  

Deltex Medical Group plc


2 Reason for the notification (please tick the appropriate box or boxes):


An acquisition or disposal of voting rights

Yes 


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 No


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 No


An event changing the breakdown of voting rights

 No


Other (please specify):

  

No 


3. Full name of person(s) subject to the notification obligation:


 Gartmore Investment Limited

4. Full name of shareholder(s) (if different from 3.):


 See attached schedule

5. Date of the transaction and date on which the threshold is crossed or reached:


 12th November 2009

6. Date on which issuer notified:


 13th November 2009

7. Threshold(s) that is/are crossed or reached:


 10%


8. Notified details:

A: Voting rights attached to shares


Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB0059337583

 12,401,111

 12,401,111

12,821,111

 

12,821,111

 

 10.290%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction


Type of financial
instrument

Expiration
date

Exercise/ 
Conversion 
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.


% of voting
rights

 

 

 

 

 


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction


Type of financial
instrument

Exercise 
price

Expiration 
date

Exercise/
Conversion 
period

Number of voting 
rights instrument 
refers to

% of voting rights


 

 

 

 

 

Nominal

Delta


 

 


Total (A+B+C)


Number of voting rights

Percentage of voting rights

 12,821,111

 10.290%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 


Proxy Voting:


10. Name of the proxy holder:


 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 


13. Additional information:


All figures are based on the Company's issued share capital of 124,598,597 as provided by Exshare


E mail contact RDU@Gartmore.com 


14. Contact name:


RDU

15. Contact telephone number:


0207 782 2324


 


Share Description

    Fund Managing Co.



Shares Held


% of Issues

Share Capital



UK Registered Owner



Beneficial Owner



Equities


    DELTEX MEDICAL GRP ORD GBP0.01


        Gartmore Fund Managers Limited


           


        Gartmore Investment Limited






6,373,804




6,447,307






5.115%




5.174%







HSBC GLOBAL CUSTODY NOMINEE UK LIMITED



VIDACOS NOMINEES LTD A/C 2303






GARTMORE FUND MANAGERS LTD A/C GARTMORE UK & IRISH SMALLER COMPANIES


THE ALPHAGEN VOLANTIS FUND LIMITED



12,821,111


10.290%















12,821,111



10.290%



















This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAFFKFLNNFFE
UK 100

Latest directors dealings